JP2013545802A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013545802A5 JP2013545802A5 JP2013544467A JP2013544467A JP2013545802A5 JP 2013545802 A5 JP2013545802 A5 JP 2013545802A5 JP 2013544467 A JP2013544467 A JP 2013544467A JP 2013544467 A JP2013544467 A JP 2013544467A JP 2013545802 A5 JP2013545802 A5 JP 2013545802A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- pharmaceutical composition
- pharmaceutically acceptable
- selective factor
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42326110P | 2010-12-15 | 2010-12-15 | |
| US61/423,261 | 2010-12-15 | ||
| PCT/US2011/052963 WO2012082209A1 (en) | 2010-12-15 | 2011-09-23 | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013545802A JP2013545802A (ja) | 2013-12-26 |
| JP2013545802A5 true JP2013545802A5 (enExample) | 2014-10-30 |
Family
ID=46234738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013544467A Pending JP2013545802A (ja) | 2010-12-15 | 2011-09-23 | 経口投与用の選択的第Ｘａ因子阻害剤の医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120156294A1 (enExample) |
| EP (1) | EP2651395A4 (enExample) |
| JP (1) | JP2013545802A (enExample) |
| KR (1) | KR20140046395A (enExample) |
| CN (1) | CN103370051A (enExample) |
| AU (1) | AU2011341637A1 (enExample) |
| BR (1) | BR112013014940A2 (enExample) |
| CA (1) | CA2819108A1 (enExample) |
| MX (1) | MX2013006877A (enExample) |
| WO (1) | WO2012082209A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
| US20110182985A1 (en) * | 2010-01-28 | 2011-07-28 | Coughlan David C | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
| EP2661273A4 (en) | 2011-01-07 | 2014-06-04 | Merrion Res Iii Ltd | IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION |
| JP7211704B2 (ja) | 2015-01-29 | 2023-01-24 | ノヴォ ノルディスク アー／エス | Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤 |
| CN108148102A (zh) * | 2016-12-03 | 2018-06-12 | 烟台东诚药业集团股份有限公司 | 喷雾干燥法制备低水分磺达肝癸钠原料药 |
| KR20190130411A (ko) | 2018-05-14 | 2019-11-22 | 신일제약주식회사 | 아픽사반 약제학적 제제 및 그의 제조방법 |
| CN117159566A (zh) * | 2022-05-26 | 2023-12-05 | 天津国际生物医药联合研究院 | 磺达肝葵钠在制备抗圣路易斯脑炎病毒感染药物中的应用 |
| US12213972B2 (en) * | 2022-07-27 | 2025-02-04 | Slayback Pharma Llc | Stable pharmaceutical compositions of apixaban |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60038097T2 (de) * | 1999-02-22 | 2009-02-12 | Merrion Research I Ltd. | Feste orale dosierungsform enthaltend einen resorptionsverstärker |
| JP2004525110A (ja) * | 2001-02-16 | 2004-08-19 | 清水製薬株式会社 | ムコ多糖類製剤およびその製造法 |
| US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
| US20070212395A1 (en) * | 2006-03-08 | 2007-09-13 | Allergan, Inc. | Ocular therapy using sirtuin-activating agents |
| BRPI0710503A2 (pt) * | 2006-04-07 | 2011-08-16 | Merrion Res Iii Ltd | uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral |
| US20090280169A1 (en) * | 2008-05-07 | 2009-11-12 | Merrion Research Iii Limited | Compositions of peptides and processes of preparation thereof |
| RU2678833C2 (ru) * | 2008-09-17 | 2019-02-04 | Киазма Инк. | Фармацевтические композиции и соответствующие способы доставки |
| US9089484B2 (en) * | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
-
2011
- 2011-09-23 AU AU2011341637A patent/AU2011341637A1/en not_active Abandoned
- 2011-09-23 MX MX2013006877A patent/MX2013006877A/es unknown
- 2011-09-23 KR KR1020137017419A patent/KR20140046395A/ko not_active Withdrawn
- 2011-09-23 EP EP11849444.2A patent/EP2651395A4/en not_active Withdrawn
- 2011-09-23 CA CA2819108A patent/CA2819108A1/en not_active Abandoned
- 2011-09-23 JP JP2013544467A patent/JP2013545802A/ja active Pending
- 2011-09-23 US US13/242,601 patent/US20120156294A1/en not_active Abandoned
- 2011-09-23 BR BR112013014940A patent/BR112013014940A2/pt not_active IP Right Cessation
- 2011-09-23 CN CN2011800604167A patent/CN103370051A/zh active Pending
- 2011-09-23 WO PCT/US2011/052963 patent/WO2012082209A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112770726B (zh) | 大麻素的缓释配方 | |
| Streubel et al. | Drug delivery to the upper small intestine window using gastroretentive technologies | |
| ES2823000T3 (es) | Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas | |
| JP3272029B2 (ja) | 消化管粘膜付着性マトリックス、製剤およびコーティング剤 | |
| JP7323451B2 (ja) | フロルグルシノールおよびトリメチルフロログルシノールの医薬製剤 | |
| JP5351490B2 (ja) | ニフェジピン含有有核錠剤およびその製法 | |
| CA2909370A1 (en) | Sustained-release formulations of colchicine and methods of using same | |
| JP2003520788A (ja) | コルチゾル拮抗物質の運搬のための組成物 | |
| JP2009535351A (ja) | シグモイド放出プロファイルを有するオキサカルバゼピンの制御放出製剤 | |
| KR20110015650A (ko) | 발사르탄의 펄스형 방출 | |
| EP2872140A1 (en) | Gastro-retentive drug delivery system | |
| CN109803684A (zh) | 用于治疗肝细胞癌的组合疗法 | |
| WO2022026519A1 (en) | Novel gastroretentive extended release dosage form | |
| RU2004127237A (ru) | Твердая препаративная форма с замедленным/контролируемым высвобождением как новая система доставки лекарственного средства со сниженным риском демпинга дозы | |
| KR101648490B1 (ko) | 위체류 약물 전달시스템을 이용한 서방성 경구용 제제 | |
| JP2013545802A (ja) | 経口投与用の選択的第Ｘａ因子阻害剤の医薬組成物 | |
| CN1642537A (zh) | 用于硬壳胶囊的布洛芬溶液 | |
| CA2833115C (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| CN108697648A (zh) | 含埃索美拉唑的制剂 | |
| KR100764727B1 (ko) | 염기성 약제 함유제제 | |
| WO2013095319A2 (en) | Formulations of flurbiprofen and diacerein | |
| WO2014007777A1 (en) | Combined capsule formulations of nsaids | |
| WO2013095320A1 (en) | Flurbiprofen formulations | |
| TW201136582A (en) | Improved pharmaceutical compositions of aliskiren and methods of delivery | |
| WO2011153168A1 (en) | Pharmaceutical compositions of ibuprofen and an h2 receptor antagonist |